CNTF and retinal degeneration: Recent results from a phase 2 clinical trial concluded that a surgical implant sutured to the pars plana that delivers ciliary neurotrophic factor (CNTF) via an encapsulated cell technology (ECT) slowed the progression of retinal degeneration in MacTel2 [56, 57].